Patents Assigned to Axim
  • Patent number: 11714083
    Abstract: The presence of analytes can be detected in the bodily fluid using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (ECS) in devices, such as handheld point-of-care devices. The devices, as well as systems and methods, utilize using Electrochemical Impedance Spectroscopy (EIS) or Electrochemical Capacitance Spectroscopy (EIS) in combination with an antibody or other target-capturing molecule on a working electrode. Imaginary impedance or phase shift, as well as background subtraction, also may be utilized.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: August 1, 2023
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH, AXIM BIOTECHNOLOGIES. INC.
    Inventors: Jeffrey LaBelle, Garrett Repp, Chi Lin, Mark Spano, Jennifer Blain Christen, Hongwu Jiang, Marcus Smith, Andrew Penman, Pierce Youngbar, Mackenzie Honikel, Curtiss Cook
  • Patent number: 11542226
    Abstract: This invention discloses cannabinoids linked with polyethylene glycol chains. The cannabinoid-polyethylene glycol chain molecules have one, two, or more cannabinoids linked with one, two, or more polyethylene glycol chains. Each cannabinoid-polyethylene glycol chain molecule may have one kind of cannabinoid or multiple kinds of cannabinoid. Methods to make these cannabinoid-polyethylene glycol linked chains are disclosed.
    Type: Grant
    Filed: April 13, 2021
    Date of Patent: January 3, 2023
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Sergei Svarovsky, John W. Huemoeller, II
  • Patent number: 11397775
    Abstract: Graphical user interfaces (GUIs) for reviewing and evaluating geospatial data are provided. A GUI may allow a user to configure a geospatial data quality assessment system by grouping feature classes into one or more categories and selecting target quality scores for the overall data set and/or one or more categories. A GUI may display one or more review areas for a user to review and allow a user to generate one or more error calls in the review areas. A GUI may display one or more scores associated with a geospatial data set. A GUI may allow a user to modify to which category one or more feature classes are assigned. In response to an adjustment of one or more feature classes between categories, the user interfaces may display one or more updated quality scores associated with one or more categories.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: July 26, 2022
    Assignee: Axim Geospatial, LLC
    Inventors: Paul Braun, Daniel Frye
  • Patent number: 10543190
    Abstract: This invention relates to a suppository composition comprising cannabinoids. The suppository composition is formulated for easy absorption through mucosal membrane. The suppository as provided herein is useful for administration of cannabinoids in patients with nausea, vomiting, other conditions preventing swallowing, or conditions wherein suppository administration is required. Methods to manufacture the suppository composition are provided. Methods to treat pain, nausea, post-operative ileus and/or inflammatory bowel diseases using the suppository according to this invention are also provided.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: January 28, 2020
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Lekhram Changoer, George Anastassov
  • Patent number: 10441552
    Abstract: This invention discloses anti-bacterial and anti-fungal compositions in spray form, in cream form, in liquid form, and in powder form. The anti-bacterial and anti-fungal compositions comprise cannabinoids, specifically cannabidiol, cannabigerol, tetrahydrocannabinol, tetracannabidivarin, and/or cannabidivarin for anti-bacterial and anti-fungal activities. The anti-bacterial and anti-fungal compositions may be used to treat toe nail fungus, MRSA infection, herpes virus infection, tinea pedis, burn wound infections, sun burns, diabetic infections, eczema, impetigo, dermatophytosis, psoriasis, itchy skin, atopic dermatitis, dandruff, and general topical infections.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: October 15, 2019
    Assignee: Axim Biotechnologies, Inc.
    Inventors: George E. Anastassov, Lekhram Changoer, Philippus Anne Van Damme
  • Patent number: 10272051
    Abstract: A method to treat the skin condition atopic dermatitis is described in this invention. The method comprises topical application of a composition containing cannabinoids, specifically cannabidiol and cannabigerol at a concentration of 3%-20% by weight of the composition. The method may further comprise administering chewing gum containing cannabinoids such as cannabidiol. Cannabidiol and cannabigerol may be sourced naturally or synthetically.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: April 30, 2019
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Lekhram Changoer, George Anastassov
  • Patent number: 10246431
    Abstract: ?9-THC carboxylic acid is extracted from cannabis flowers using a first organic solvent, then separated using a second aqueous solvent. ?9-THC carboxylic acid is converted to ?9-THC carboxylic salt before being extracted by a third organic solvent and converted back to ?9-THC carboxylic acid. Using a solvent swap, ?9-THC carboxylic acid is decarboxylated and extracted again with an organic solvent prior to purification to give ?9-THC.
    Type: Grant
    Filed: August 1, 2018
    Date of Patent: April 2, 2019
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Lekhram Changoer, Cornelis Herman Michel Van Der Loo, Erik Keller
  • Patent number: 10172786
    Abstract: This application discloses oral care compositions comprising cannabinoids, preferably cannabidiol and/or cannabigerol. The oral care composition disclosed in this application may be a tooth paste, a tooth powder, or a mouthwash solution. The oral care composition may be used to treat oral infectious disease, including periimplantitis, periodontitis, oral mucositis, and dental pain.
    Type: Grant
    Filed: December 15, 2015
    Date of Patent: January 8, 2019
    Assignee: Axim Biotechnologies, Inc.
    Inventors: George Anastassov, Lekhram Changoer
  • Patent number: 10092538
    Abstract: This invention relates to a suppository composition comprising cannabinoids. The suppository composition is formulated for easy absorption through mucosal membrane. The suppository as provided herein is useful for administration of cannabinoids in patients with nausea, vomiting, other conditions preventing swallowing, or conditions wherein suppository administration is required. Methods to manufacture the suppository composition are provided. Methods to treat pain, nausea, post-operative ileus and/or inflammatory bowel diseases using the suppository according to this invention are also provided.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: October 9, 2018
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Lekhram Changoer, George Anastassov
  • Patent number: 10059684
    Abstract: ?9-THC acid is extracted from cannabis flowers using a first organic solvent, then separated using a second aqueous solvent. ?9-THC acid is converted to ?9-THC carboxylic salt before being extracted by a third organic solvent and converted back to ?9-THC carboxylic acid. Using a solvent swap, ?9-THC carboxylic acid is decarboxylated and extracted again with an organic solvent prior to purification to give ?9-THC.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: August 28, 2018
    Assignee: Axim Biotechnologies, Inc.
    Inventors: Lekhram Changoer, Cornelis Herman Michel Van Der Loo, Erik Keller
  • Patent number: 9844530
    Abstract: This invention generally relates to methods of treatment of glaucoma and symptomatic relief of conjunctival inflammation. An ophthalmic solution comprising cannabinoids for the treatment of glaucoma and an ophthalmic solution comprising cannabinoids for these purposes are disclosed. Cannabinoids are selected to achieve the specific purpose of the respective ophthalmic solution.
    Type: Grant
    Filed: October 9, 2017
    Date of Patent: December 19, 2017
    Assignee: Axim Biotechnologies, Inc.
    Inventors: George Anastassov, Lekhram Changoer
  • Patent number: 9814695
    Abstract: This invention generally relates to an ophthalmic solution comprising cannabinoids for the treatment of glaucoma. Also disclosed is an ophthalmic solution comprising cannabinoids for symptomatic relief of conjunctival inflammation. Cannabinoids are selected to achieve the specific purpose of the respective ophthalmic solution.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: November 14, 2017
    Assignee: Axim Biotechnologies, Inc.
    Inventors: George Anastassov, Lekhram Changoer
  • Patent number: 5976242
    Abstract: A hydraulic-cement setting retarder included in concrete, mortars, or grouts to control setting time as a function of the retarder dosage. Specifically, the retarder is a cyclic amino resin of formula (I): ##STR1## where (a) R1 is a hydrogen atom, a hydroxymethal radial or a group of formula (II)CH.sub.2 --O--R (II)(b) R.sub.2 is a group of formula (II),(c) R is a linear or branched C1-C4 alkyl radical, or a group of formula (III) ##STR2## (d) R.sub.3 and R.sub.4 each are a hydrogen atom, and C1-C4 linear or branched alkyl radical or a group of formula (III).
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: November 2, 1999
    Assignee: Axim
    Inventors: Alain Blanc, Catherine Fontaine
  • Patent number: 5028267
    Abstract: The thixotropic reaction that takes place in an aqueous dispersion of micro silica is delayed by the addition of a pre-determined amount of at least one chemical additive selected from the group consisting of amides, such as carbamide, or polyols, such as glycerol and propylene glycol.
    Type: Grant
    Filed: May 3, 1990
    Date of Patent: July 2, 1991
    Assignee: Axim Concrete Technologies, Inc.
    Inventors: Donald R. Lane, Jose A. Melendez